Scythian Biosciences Corp. Announces Ringing of the Nasdaq Stock Market Closing Bell
February 22, 2018 08:00 ET
|
Scythian Biosciences Corp.
TORONTO, Feb. 22, 2018 (GLOBE NEWSWIRE) -- Scythian Biosciences Corp. (the "Company" or “Scythian”) (TSXV:SCYB) (Frankfurt:9SB) (OTCQB:SCCYF) is pleased to announce that the Company will ring the...
Scythian Biosciences Announces Appointment of Professor Michael Barnes as Chief Medical Officer
February 15, 2018 08:20 ET
|
Scythian Biosciences Corp.
- Influential voice in medical cannabis policy in Europe - A leading world authority in neurological rehabilitation TORONTO, Feb. 15, 2018 (GLOBE NEWSWIRE) -- Scythian Biosciences Corp. (the...
Scythian Biosciences Corp. Announces Approval for Listing on the Nasdaq Capital Markets under Symbol “SCYB” and Ringing of the Nasdaq Closing Bell
February 14, 2018 08:30 ET
|
Scythian Biosciences Corp.
TORONTO, Feb. 14, 2018 (GLOBE NEWSWIRE) -- Scythian Biosciences Corp. (the “Company” or “Scythian”) (TSXV:SCYB) (Frankfurt:9SB) (OTCQB:SCCYF) is pleased to announce that the Company has received...
Scythian Biosciences Announces Closing of $28.7 Million Financing with Aphria Inc. as Lead Investor
February 13, 2018 09:18 ET
|
Scythian Biosciences Corp.
TORONTO, Feb. 13, 2018 (GLOBE NEWSWIRE) -- Scythian Biosciences Corp. (the "Company" or “Scythian”) (TSXV:SCYB) (Frankfurt:9SB) (OTCQB:SCCYF) is pleased to announce that it has today closed its...
Scythian Biosciences Announces CEOs of Both Aphria and Liberty Health Sciences are Joining its Board
January 15, 2018 08:30 ET
|
Scythian Biosciences Corp.
TORONTO, Jan. 15, 2018 (GLOBE NEWSWIRE) -- Scythian Biosciences Corp. (the "Company" or “Scythian”) (TSXV:SCYB) (Frankfurt:9SB) (OTCQB:SCCYF) is pleased to announce that Mr. Vic Neufeld and Mr....
Scythian Biosciences Corp. Announces Upgrade to the OTCQB Marketplace
January 10, 2018 09:00 ET
|
Scythian Biosciences Corp.
TORONTO, Jan. 10, 2018 (GLOBE NEWSWIRE) -- Scythian Biosciences Corp. (the "Company" or “Scythian”) (TSX-V:SCYB) (Frankfurt:9SB) (OTCQB:SCCYF) is pleased to announce that it has been upgraded to the...
Scythian Biosciences Corp. Announces Proposed Up To 8 for 1 Stock Split
January 04, 2018 09:00 ET
|
Scythian Biosciences Corp.
TORONTO, Jan. 04, 2018 (GLOBE NEWSWIRE) -- Scythian Biosciences Corp. (the "Company" or “Scythian”) (TSX-V:SCYB) (Frankfurt:9SB) (OTC Pink:SCCYF) announces that its Board of Directors has approved a...
Scythian Biosciences Corp. Announces Appointment of Ottis Anderson to Pro Athlete Advisory Committee
December 11, 2017 17:07 ET
|
Scythian Biosciences Corp.
TORONTO, Dec. 11, 2017 (GLOBE NEWSWIRE) -- Scythian Biosciences Corp. (the "Company" or “Scythian”) (TSXV:SCYB) (Frankfurt:9SB) (OTC Pink:SCCYF) is pleased to announce that it has appointed Ottis...
Scythian Biosciences Corp. Completes Sale of Go Green
November 30, 2017 09:00 ET
|
Scythian Biosciences Corp.
TORONTO, Nov. 30, 2017 (GLOBE NEWSWIRE) -- Scythian Biosciences Corp. (the "Company" or “Scythian”) (TSX-V:SCYB) (Frankfurt:9SB) (OTC Pink:SCCYF) is pleased to announce that it has entered into a...
Scythian Retains Investor Relations Services
October 18, 2017 17:00 ET
|
Scythian Biosciences Corp.
TORONTO, Oct. 18, 2017 (GLOBE NEWSWIRE) -- Scythian Biosciences Corp. (the "Company" or “Scythian”) (TSX-V:SCYB) (Frankfurt:9SB) (OTC Pink:SCCYF) announces that is has entered into an agreement with...